
Monopar Therapeutics (MNPR) Earnings Dates & Reports
Monopar Therapeutics (MNPR) Most Recent Earnings
Report Date
Period EndingQ1 2026
Est. EPS-$0.93
Actual EPS-$0.46
EarningsBeat
Monopar Therapeutics (MNPR) Earnings
View the latest Monopar Therapeutics (MNPR) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Monopar Therapeutics (MNPR)
Order type
Buy in
Order amount
Est. shares
0 shares
Monopar Therapeutics (MNPR) Earnings per Share (EPS) History
Signup for full accessBrowse free
Monopar Therapeutics (MNPR) Latest Earnings
The value each MNPR share was expected to gain vs. the value each share gained.
Monopar Therapeutics (MNPR) reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of -$0.46. This exceeded analysts' expectations of -$0.93 by 50.54%, marking a Beat.
For comparison, Monopar Therapeutics reported EPS of -$0.38 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.77.
Monopar Therapeutics (MNPR) Earnings History
Monopar Therapeutics (MNPR) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Monopar Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Monopar Therapeutics (MNPR) Earnings FAQs
Monopar Therapeutics (MNPR) last reported earnings on May 14, 2026 for Q1 2026, posting an EPS of -$0.46, which Beat the estimate of -$0.93 by 50.54%.
For Q1 2026, Monopar Therapeutics (MNPR) reported an EPS of -$0.46, exceeding analysts' estimate of -$0.93 by 50.54%.
For Q1 2026, Monopar Therapeutics (MNPR) Beat expectations with an actual EPS of -$0.46 vs. an estimated EPS of -$0.93.
Following the last earnings report on May 14, 2026, Monopar Therapeutics (MNPR)'s stock price moved — from — to —.
The next Monopar Therapeutics (MNPR) earnings call is scheduled for Aug. 11, 2026, where executives will discuss financial results and outlook.